| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 9.1e-05 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -9e-05 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -2.1e-05 | 1 |